.

Make Better Decisions

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fuji
Merck
QuintilesIMS
Argus Health
Novartis
Baxter
Daiichi Sankyo
Mallinckrodt
Covington
Dow

Generated: December 18, 2017

DrugPatentWatch Database Preview

Stiefel Company Profile

« Back to Dashboard

What is the competitive landscape for STIEFEL, and what generic and branded alternatives to STIEFEL drugs are available?

STIEFEL has five approved drugs.



Summary for Stiefel

US Patents:0
Tradenames:4
Ingredients:4
NDAs:5
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
StiefelSCABENElindaneLOTION;TOPICAL086769-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
StiefelSCABENElindaneSHAMPOO;TOPICAL087940-001Apr 8, 1983DISCNNoNo► Subscribe► Subscribe► Subscribe
Stiefel Labs IncSORIATANEacitretinCAPSULE;ORAL019821-003Aug 6, 2009ABRXYesNo► Subscribe► Subscribe► Subscribe
StiefelDUACbenzoyl peroxide; clindamycin phosphateGEL;TOPICAL050741-001Aug 26, 2002ABRXYesYes► Subscribe► Subscribe► Subscribe
Stiefel Labs IncSORIATANEacitretinCAPSULE;ORAL019821-004Aug 6, 2009ABRXYesNo► Subscribe► Subscribe► Subscribe
Stiefel Labs IncSORIATANEacitretinCAPSULE;ORAL019821-001Oct 28, 1996ABRXYesNo► Subscribe► Subscribe► Subscribe
Stiefel Labs IncSORIATANEacitretinCAPSULE;ORAL019821-002Oct 28, 1996ABRXYesYes► Subscribe► Subscribe► Subscribe
StiefelHYDROCORTISONEhydrocortisoneCREAM;TOPICAL086170-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Stiefel

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
StiefelDUACbenzoyl peroxide; clindamycin phosphateGEL;TOPICAL050741-001Aug 26, 2002► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for STIEFEL drugs

Drugname Dosage Strength Tradename Submissiondate
clindamycin phosphate and benzoyl peroxideGel1% / 5%DUAC12/11/2008

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Julphar
Accenture
Queensland Health
Healthtrust
Johnson and Johnson
Medtronic
Harvard Business School
US Department of Justice
Moodys
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot